Screening infants exposed to hepatitis C virus infection during pregnancy in Grampian, UK: a review

Emmanuel Okpo; Lynn Byers

doi:10.1016/S0140-6736(19)32871-5

Screening infants exposed to hepatitis C virus infection during pregnancy in Grampian, UK: a review

Emmanuel Okpo, Lynn Byers

Applied Health Sciences

Research output: Chapter in Book/Report/Conference proceeding › Published conference contribution

Abstract

Prevalence of maternal hepatitis C virus infection is increasing globally and vertical transmission is the main route of transmission in children. The risk of infection is about 5% and about 80% of infected infants will develop chronic infection. In Scotland, risk-based screening for hepatitis C is offered to pregnant women who have ever been injecting drug users (IDUs) and testing from age 12 months for all infants exposed to hepatitis C virus during pregnancy is recommended by The Scottish Intercollegiate Guidelines Network.

Original language	English
Title of host publication	Screening infants exposed to hepatitis C virus infection during pregnancy in Grampian, UK: a review
Publisher	The Lancet
Number of pages	1
Volume	394
Edition	Special S74
DOIs	https://doi.org/10.1016/S0140-6736(19)32871-5
Publication status	Published - 28 Nov 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S0140-6736(19)32871-5

Cite this

Screening infants exposed to hepatitis C virus infection during pregnancy in Grampian, UK: a review. / Okpo, Emmanuel; Byers, Lynn.
Screening infants exposed to hepatitis C virus infection during pregnancy in Grampian, UK: a review. Vol. 394 Special S74. ed. The Lancet, 2019.

Research output: Chapter in Book/Report/Conference proceeding › Published conference contribution

@inproceedings{0f666ca642664e6884a6458cbc8a5f97,

title = "Screening infants exposed to hepatitis C virus infection during pregnancy in Grampian, UK: a review",

abstract = "Prevalence of maternal hepatitis C virus infection is increasing globally and vertical transmission is the main route of transmission in children. The risk of infection is about 5% and about 80% of infected infants will develop chronic infection. In Scotland, risk-based screening for hepatitis C is offered to pregnant women who have ever been injecting drug users (IDUs) and testing from age 12 months for all infants exposed to hepatitis C virus during pregnancy is recommended by The Scottish Intercollegiate Guidelines Network.",

author = "Emmanuel Okpo and Lynn Byers",

year = "2019",

month = nov,

day = "28",

doi = "10.1016/S0140-6736(19)32871-5",

language = "English",

volume = "394",

booktitle = "Screening infants exposed to hepatitis C virus infection during pregnancy in Grampian, UK: a review",

publisher = "The Lancet",

edition = "Special S74",

}

TY - GEN

T1 - Screening infants exposed to hepatitis C virus infection during pregnancy in Grampian, UK: a review

AU - Okpo, Emmanuel

AU - Byers, Lynn

PY - 2019/11/28

Y1 - 2019/11/28

N2 - Prevalence of maternal hepatitis C virus infection is increasing globally and vertical transmission is the main route of transmission in children. The risk of infection is about 5% and about 80% of infected infants will develop chronic infection. In Scotland, risk-based screening for hepatitis C is offered to pregnant women who have ever been injecting drug users (IDUs) and testing from age 12 months for all infants exposed to hepatitis C virus during pregnancy is recommended by The Scottish Intercollegiate Guidelines Network.

AB - Prevalence of maternal hepatitis C virus infection is increasing globally and vertical transmission is the main route of transmission in children. The risk of infection is about 5% and about 80% of infected infants will develop chronic infection. In Scotland, risk-based screening for hepatitis C is offered to pregnant women who have ever been injecting drug users (IDUs) and testing from age 12 months for all infants exposed to hepatitis C virus during pregnancy is recommended by The Scottish Intercollegiate Guidelines Network.

U2 - 10.1016/S0140-6736(19)32871-5

DO - 10.1016/S0140-6736(19)32871-5

M3 - Published conference contribution

VL - 394

BT - Screening infants exposed to hepatitis C virus infection during pregnancy in Grampian, UK: a review

PB - The Lancet

ER -

Screening infants exposed to hepatitis C virus infection during pregnancy in Grampian, UK: a review

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this